Literature DB >> 1645577

Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.

E J Wawrzynczak1, E J Derbyshire, R V Henry, G D Parnell, A Smith, R Waibel, R A Stahel.   

Abstract

The potential of mouse monoclonal antibodies raised against the human small cell lung cancer (SCLC) cell line SW2 to form active immunotoxins was evaluated using an indirect assay of immunotoxin cytotoxicity. Monoclonal antibodies recognising different SCLC-associated antigens, designated as cluster w4 and cluster 5A antibodies by the First International Workshop on SCLC Antigens, mediated the cytotoxic action of a screening agent made by linking ricin A chain to sheep anti-mouse IgG Fab' fragment. In contrast, monoclonal antibodies belonging to cluster 1 gave no significant cytotoxic effects in conjunction with the screening agent. Immunotoxins made by the direct chemical conjugation of ricin A chain to SWA11 (cluster w4) and SWA20 (cluster 5A) both exhibited selective toxic effects upon the SW2 cell line in tissue culture, inhibiting the incorporation of 3H-leucine by 50% at a concentration (IC50) of approximately 3 x 10(-10) M. An immunotoxin made with SEN36 (cluster 1) was much less potent with an IC50 greater than 1 x 10(-8) M.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645577      PMCID: PMC2204099     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  9 in total

1.  Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer.

Authors:  J K Weltman; P Pedroso; S A Johnson; D Davignon; L D Fast; L A Leone
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

2.  An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.

Authors:  M Till; R D May; J W Uhr; P E Thorpe; E S Vitetta
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

3.  Preparation of antibody-toxin conjugates.

Authors:  A J Cumber; J A Forrester; B M Foxwell; W C Ross; P E Thorpe
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

4.  Tumor-associated membrane sialoglycoprotein on human small cell lung carcinoma identified by the IgG2a monoclonal antibody SWA20.

Authors:  R Waibel; C J O'Hara; A Smith; R A Stahel
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

5.  Delivery of ricin and abrin A-chains to human carcinoma cells in culture following covalent linkage to monoclonal antibody LICR-LOND-Fib 75.

Authors:  J A Forrester; D P McIntosh; A J Cumber; G D Parnell; W C Ross
Journal:  Cancer Drug Deliv       Date:  1984

6.  Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma and neuroblastoma.

Authors:  K Patel; S E Moore; G Dickson; R J Rossell; P C Beverley; J T Kemshead; F S Walsh
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

7.  Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11.

Authors:  A Smith; R Waibel; G Westera; A Martin; A T Zimmerman; R A Stahel
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

8.  Expression of the small cell carcinoma antigens of cluster-5 and cluster-5A in primary lung tumours.

Authors:  A Maier; U Schmidt; R Waibel; W Hartung; R A Stahel
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

9.  Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.

Authors:  E J Wawrzynczak; E J Derbyshire; R V Henry; G D Parnell; A Smith; R Waibel; R A Stahel
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

  9 in total
  6 in total

1.  Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.

Authors:  E J Derbyshire; R A Stahel; E J Wawrzynczak
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion molecule.

Authors:  E J Derbyshire; R A Stahel; E J Wawrzynczak
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

3.  Immunotoxin Therapy for Lung Cancer.

Authors:  Li-Yi Xie; Hai-Lan Piao; Min Fan; Zhen Zhang; Chen Wang; Darell D Bigner; Xu-Hui Bao
Journal:  Chin Med J (Engl)       Date:  2017-03-05       Impact factor: 2.628

4.  Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.

Authors:  U Zangemeister-Wittke; A R Collinson; B Frösch; R Waibel; T Schenker; R A Stahel
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 9.075

5.  Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.

Authors:  E J Derbyshire; L de Leij; E J Wawrzynczak
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

6.  Biodistribution and tumour localisation of 131I SWA11 recognising the cluster w4 antigen in patients with small cell lung cancer.

Authors:  J A Ledermann; N J Marston; R A Stahel; R Waibel; J R Buscombe; P J Ell
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.